Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia
Jonas, U.; Melchior, H.; Rübben, H.
Der Urologe. Ausg. a 37(1): 110-111
1998
ISSN/ISBN: 0340-2592 PMID: 9540196 Document Number: 492910
Document emailed within 1 workday
Related Documents
Hanus, M.; Matousková, M. 1993: Antiestrogens (tamoxifen) in the alternative therapy of benign prostatic hyperplasia Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 72(7): 316-318Ekman, P. 1992: Drug therapy of benign prostatic hyperplasia Lakartidningen 89(45): 3803-3804
Goldfarb, B.; Bartkiw, T.; Trachtenberg, J. 1995: Microwave therapy of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 431-439
Trinkler, F.B. 1997: Therapy of benign prostatic hyperplasia: terazosin or finasteride? Praxis 86(34): 1305-1306
Madersbacher, S.; Marberger, M. 1996: Minimal invasive therapy of benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 169-175
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Drsata, J. 2002: Enzyme inhibition in the drug therapy of benign prostatic hyperplasia Casopis Lekaru Ceskych 141(20): 630-635
Savage, S.J..; Spungen, A.M..; Galea, G.; Britanico, J.; Vapnek, J.M.. 1998: Combination medical therapy for symptomatic benign prostatic hyperplasia Canadian Journal of Urology 5(3): 578-584
Effert, P.; Ackermann, R. 1992: Clinical manifestations and indications for therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 31(3): 135-141
Göbel, A. 1999: Benign prostatic hyperplasia; recommendations for transmural care Nederlands Tijdschrift Voor Geneeskunde 143(6): 327
Schlatmann, T.J. 1992: Benign prostatic hyperplasia; recommendations for diagnosis and treatment in 1992 Nederlands Tijdschrift Voor Geneeskunde 136(49): 2414-2417
Ustinov, D.V.; Kholtobin, D.P.; Kul'chavenia, E.V.; Aĭzikovich, B.I. 2013: The use of laser vaporization for the treatment of benign prostatic hyperplasia Urologiia 4: 74
Liu, J.; Kang, S.-S.; Zhang, X.-J.; Cao, F.-H.; Li, X.-Q. 2013: 980 nm diode laser vaporization for benign prostatic hyperplasia Zhonghua Nan Ke Xue 19(5): 422-424
Chepurov, A.K. 1999: Holmium laser treatment of benign prostatic hyperplasia Urologiia 4: 39-41
Umeda, H.; Yoshimura, Y.; Yamaguchi, O.; Kumakawa, K.; Shiraiwa, Y. 1997: Transurethral balloon laser thermotherapy for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 43(6): 415-419
Granados, E.A. 1998: Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery Archivos Espanoles de Urologia 51(7): 675-679
Takayama, T.; Arakawa, I.; Kakihara, H.; Tachibana, K.; Ozono, S. 2012: Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan Hinyokika Kiyo. Acta Urologica Japonica 58(2): 61-69
Muschter, R.; Zellner, M.; Hessel, S.; Hofstetter, A. 1994: Interstitial laser coagulation of the prostate: experiences in the treatment of benign prostatic hyperplasia Progress in Clinical and Biological Research 386: 521-527
Larcher, P.; Borroni, G.; Begani, A.; Franch, P.; Grisotto, M. 2005: The use of vesical irrigation system dual pump Endo FMS urology in the endoscopic therapy of benign prostatic hyperplasia Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 77(2): 139-140
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133